Navigation Links
Stress, a 'Type A' Personality May Boost Stroke Risk
Date:8/30/2012

By Denise Mann
HealthDay Reporter

THURSDAY, Aug. 30 (HealthDay News) -- Stressed-out, type A personalities may be more likely to suffer a stroke than their mellow counterparts, a new Spanish study suggests.

Previous research has linked stress to heart disease, but this latest finding, which appears online Aug. 29 in the Journal of Neurology, Neurosurgery and Psychiatry, looked at stress in relation to stroke risk.

Researchers from the Hospital Clinico Universitario San Carlos in Madrid compared stroke risk factors, including stress levels, among 150 adults who had a stroke and 300 healthy adults (the "control" group). Stress levels were measured using standardized tools assessing major life events, anxiety and depression, general well-being and personality type. Participants also answered questions about their caffeine, alcohol and energy drink intake, smoking status and whether or not they had a job.

Having had a stressful major life event in the past year quadrupled the risk of stroke, while having a type A personality doubled the chances, according to Dr. Jose Antonio Egido and colleagues. Smoking or having smoked in the past also doubled the chances, the investigators found.

"Addressing the influence of psychophysical factors on stroke could constitute an additional therapeutic line in the primary prevention of stroke in the at-risk population and, as such, warrants further investigation," the study authors concluded.

Experts agreed the finding could help doctors better understand the effect of stress on stroke risk. But while the study did show an association between the two it did not prove cause and effect.

"This study is useful and valuable because it shows us that there is an association between stress, type A personalities and stroke risk," said Dr. Deepak Bhatt, director of the integrated cardiovascular intervention program at Brigham and Women's Hospital in Boston. "Stress
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Acai counteracts oxidative stress, lengthens lifespan in fruit flies
2. Immigrant women giving birth in Spain suffer great stress, a study warns
3. Email vacations decrease stress, increase concentration, researchers say
4. Confusion Over Diabetes Types Adds to Patients Woes
5. Parents and readers beware of stereotypes in young adult literature
6. Obese and overweight women face increased risk of recurrence of most common type of breast cancer
7. Weight-Loss Surgery May Help Prevent Type 2 Diabetes
8. Your Blood Type May Boost Your Heart Risk, Study Finds
9. Pain Reported by Nearly Half With Type 2 Diabetes
10. Scientists ID New Gene Regions Linked to Type 2 Diabetes
11. Existing drugs offer new treatment options for high-risk childhood leukemia subtype
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
(Date:4/17/2014)... Alliance, a nonprofit organization that focuses on conservation and ... examining the current state of knowledge of the deadly ... global surveillance strategies to combat the emergence of infectious ... West Africa that has claimed the lives of 122 ... According to the World Health Organization (WHO), the deadly ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... , ATLANTA, Sept. 8 Craneware, Inc. (AIM: CRW.L), a leader in ... for the year ended June 30, 2009. , , Financial ... of contracted sales in the year totaling $43.2m (FY08: $25.7m), 68% up from the ... increase in revenues to $23.0m (FY08: $18.7m) , ...
... , Senators Bob Dole and Tom Daschle join ... bipartisan agreement in health reform , , ... Health Care Together will host a bipartisan health care forum to ... the health reform debate. The event entitled, "Common Sense Collaboration: ...
... , , , BRISTOL, Va. ... and HealthSouth Corporation (NYSE: HLS ) today announced that ... awarded a certificate of public need (COPN) to open a new ... more patients in Bristol and throughout Southwest Virginia to have access ...
... , , , ... Sept. 8 Reportlinker.com announces that a new market research report ... Gastrointestinal Endoscopy Devices , , ... the US market for Gastrointestinal Endoscopy Devices in Millions of US$ ...
... , , Texas ... Jobs, Improve Patient Access to Care , , ... period filled with wide-ranging local discussion of health care reform, the Texas ... care reform in Washington can help drive momentum and discussion in Texas ...
... , SOMERSET, N.J., Sept. 8 ... of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United ... insomnia characterized by difficulties with falling asleep. EDLUAR is ... is the most prescribed treatment for insomnia. Zolpidem tartrate ...
Cached Medicine News:Health News:Craneware Announces Fiscal Year-End Results 2Health News:Craneware Announces Fiscal Year-End Results 3Health News:Bipartisan Policy Center and Better Health Care Together to Host Joint Health Care Forum Tomorrow 2Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 2Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 3Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 4Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 5Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 2Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 3Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 4Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 5Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 6Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 7Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 8Health News:Texas Kidney Community Expresses Hope DC Health Care Reform Debate Can Help Drive Continued Progress in Texas Opening Needed Dialysis Facilities 2Health News:Texas Kidney Community Expresses Hope DC Health Care Reform Debate Can Help Drive Continued Progress in Texas Opening Needed Dialysis Facilities 3Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 2Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 3Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 4
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, Inc., ... unmet needs of severely obese patients, today announced ... beloranib, a selective inhibitor of methionine aminopeptidase 2 ... severe form of genetic obesity.  These results showed ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Pa., Oct. 29 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today ... Credit Suisse Healthcare Conference to be held November 10-12, 2010 ... Fickenscher, Chief Financial Officer, is scheduled to present an overview ... ET on Thursday, November 11, 2010. To listen ...
... Calif., Oct. 28 VIVUS, Inc. (Nasdaq: ... Response Letter (CRL) from the U.S. Food and Drug ... the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The ... the NDA cannot be approved in its present form. ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 2FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 4FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 5
Portable shields for your safety and convenience....
The Bronze Metalite Constructed of optical-grade steel with bronze electroplate. Fitted lead side shields that create a seal to the front of the lenses for increased scatter protection....
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures....
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Medicine Products: